The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Notice for afamelanotide (Clinuvel Pharmaceuticals Ltd)
Active ingredients
afamelanotide
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Subcutaneous implant
Indication
For the treatment of erythropoietic porphyrias